Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes. 2022

Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
Department of Immunology and Microbiology, School of Medicine, University of Colorado, Aurora, CO, United States.

Insulin is considered to be a key antigenic target of T cells in Type 1 Diabetes (T1D) and autoimmune diabetes in the NOD mouse with particular focus on the B-chain amino acid sequence B:9-23 as the primary epitope. Our lab previously discovered that hybrid insulin peptides (HIPs), comprised of insulin C-peptide fragments fused to other β-cell granule peptides, are ligands for several pathogenic CD4 T cell clones derived from NOD mice and for autoreactive CD4 T cells from T1D patients. A subset of CD4 T cell clones from our panel react to insulin and B:9-23 but only at high concentrations of antigen. We hypothesized that HIPs might also be formed from insulin B-chain sequences covalently bound to other endogenously cleaved ß-cell proteins. We report here on the identification of a B-chain HIP, termed the 6.3HIP, containing a fragment of B:9-23 joined to an endogenously processed peptide of ProSAAS, as a strong neo-epitope for the insulin-reactive CD4 T cell clone BDC-6.3. Using an I-Ag7 tetramer loaded with the 6.3HIP, we demonstrate that T cells reactive to this B-chain HIP can be readily detected in NOD mouse islet infiltrates. This work suggests that some portion of autoreactive T cells stimulated by insulin B:9-23 may be responding to B-chain HIPs as peptide ligands.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D016688 Mice, Inbred NOD A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked. Non-Obese Diabetic Mice,Mice, NOD,Mouse, Inbred NOD,Mouse, NOD,Non-Obese Diabetic Mouse,Nonobese Diabetic Mice,Nonobese Diabetic Mouse,Diabetic Mice, Non-Obese,Diabetic Mice, Nonobese,Diabetic Mouse, Non-Obese,Diabetic Mouse, Nonobese,Inbred NOD Mice,Inbred NOD Mouse,Mice, Non-Obese Diabetic,Mice, Nonobese Diabetic,Mouse, Non-Obese Diabetic,Mouse, Nonobese Diabetic,NOD Mice,NOD Mice, Inbred,NOD Mouse,NOD Mouse, Inbred,Non Obese Diabetic Mice,Non Obese Diabetic Mouse
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
August 2019, Current opinion in endocrinology, diabetes, and obesity,
Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
September 2018, Diabetes,
Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
May 2009, Diabetes,
Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
January 2020, mAbs,
Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
November 2003, Journal of autoimmunity,
Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
August 2004, Journal of autoimmunity,
Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
September 2019, Diabetes,
Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
October 2014, Proceedings of the National Academy of Sciences of the United States of America,
Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
November 2019, Clinical immunology (Orlando, Fla.),
Janet M Wenzlau, and James E DiLisio, and Gene Barbour, and Mylinh Dang, and Anita C Hohenstein, and Maki Nakayama, and Thomas Delong, and Rocky L Baker, and Kathryn Haskins
July 2006, Diabetes,
Copied contents to your clipboard!